count and viral load suppression, modeling age with seven and four knots, respectively, fit the 1 2 0 data best. For the outcome of nonadherence, modeling age as linear fit the data best. We tested 1 2 1 for a relationship between age and each outcome using the likelihood ratio test. To examine 1 2 2 whether the overall association between age and viral suppression was driven by an increasing 1 2 3 probability of viral suppression at younger ages, versus a declining probability of suppression 1 2 4 during adolescence, we tested for an association between older age (16-18 years) versus 1 2 5 younger age (10-12 years) in the subset of measurements taken from 10 to 18 years of age. Analyses were conducted in SAS version 9.4 (Cary, NC). This study was reviewed and retrospective chart review. were included in the analysis. The median age at the time of the chart review was 14.6 years relationship between age and CD4 count (p=0.02, Figure 1 ). The mean CD4 count trended
downward during childhood and decreased at a faster rate after approximately 12.8 years of Over the follow up period, patients had a median of 12 viral load measurements after having between assessments was 6.0 months (25 th percentile=5.8 months, 75 th percentile=6.7 months).
Of 1,531 viral loads among 128 patients, 1,115 (73%) were suppressed (<400 copies/ml). At
least one suppressed viral load was observed in 123 (96%) patients. We observed a non-linear suppressed. By 18 years of age (216 months), suppression rates decreased to 67% (95% CI:
47, 83). When we examined the association between age and viral load suppression during
adolescence, we found a significantly lower predicted probability (p=0.02) of viral load 1 6 7 suppression in older adolescence (i.e., 16 to 18 years of age) than younger adolescence (i.e., 10 to 12 years of age). proportion with a nonadherence note increased with age in a log-linear fashion (p<0.0001, 1 7 5 Figure 1 ). At five years of age (60 months), the predicted proportion of patients with a 1 7 6
nonadherence note was 0.8% (95% CI: 0.5, 1.3) which increased to 11% (95% CI: 7, 15) by 18
years of age (216 months). population supports that adherence suffers during adolescence and that the mechanisms survey implemented in this study population, we found self-reported nonadherence was greatest individual-and family/caregiver-levels, providing the ideal opportunity to deliver support or responsibility for their care is transferred from caregiver to the adolescent, health education on provided early on in adolescence. during early adolescence and occurred in accordance with provider-reported nonadherence.
3 4
Research on effective, tailored interventions aimed at improving clinical outcomes and 2 3 5
adherence during adolescence are needed in this population. 
